Agenda Overview

Preconference - Compliance Sessions

Preconference Symposiums

Day 1

Day 2

Congress Agenda : Overview

Wednesday, December 8, 1999
Preconference Compliance Session and Preconference Symposium

Featuring:

• Provider Quality and Cost Management Strategies
• Pharmaceutical Representative Training
• Scientific Developments
• Distribution Innovation
• Wall Street's Perspective
• Pharmaceutical Compliance

Thursday, December 9, 1999
National Congress - Day One

Featuring:

	Stuart Altman, Ph.D. Sol C. Chaikin Professor of National Health Policy Institute of Health Policy, Heller Graduate School Brandeis University Waltham, MA
	Susan Horn, Ph.D. Senior Scientist Institute for Clinical Outcomes Research Salt Lake City, UT
	Jerome P. Kassirer, M.D. Editor, New England Journal of Medicine Boston, MA
	William B. Schwartz, M.D. Professor of Medicine, USC School of Medicine and Author of Life Without Disease: The Pursuit of Medical Utopia Los Angeles, CA
	Stephen Soumerai, Sc.D. Director, Drug Policy Research Program Harvard Medical School and Harvard Pilgrim Health Care Boston, MA
	Karen Williams President National Pharmaceutical Council Reston, VA
	Ron Winslow Health & Medicine Reporter Wall Street Journal New York, NY

	Mary Jane England, M.D. President Washington Business Group on Health Washington, D.C
	Alan Holmer President Pharmaceutical Research and Manufacturers of America Washington, D.C.
	Karen Ignagni President and Chief Executive Officer American Association of Health Plans Washington, D.C.
	Professor Uwe Reinhardt, Ph.D. James Madison Professor of Political Economy Princeton University Princeton, NJ
	Samuel Thier, M.D. President and CEO Partners Healthcare System, Inc. Boston, MA
	Reed Tuckson, M.D. Senior Vice President for Professional Standards American Medical Association Chicago, IL

Back to Top